...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Shareholder Value
8
Aug 06, 2021 10:32AM
1
Aug 06, 2021 09:33PM
6
Aug 06, 2021 10:09PM
2
Aug 07, 2021 08:46AM
2
Aug 07, 2021 12:02PM
6
Aug 07, 2021 01:41PM

Totally agree with your take Toinv, the lack of skill demonstrated at CEO is appalling in both companies

Share
New Message
Please login to post a reply